Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; none of the 50 sources its claims cite is checked for support yet.
Abstract
Background: Influence of sarcopenia in combination with other body composition parameters and muscle strength on outcomes after oesophageal surgery for oesophageal cancer remains unclear. The objectives were (i) to describe the incidence of sarcopenia in relation to adipose tissue quantity and distribution and muscle strength; (ii) to evaluate if neoadjuvant chemoradiation (nCRTx) influences body composition and muscle strength; and (iii) to evaluate the influence of body composition and muscle strength on post‐operative morbidity and long‐term survival. Methods: This retrospective study included patients with oesophageal cancer who received nCRTx followed by surgery between January 2011 and 2016. Skeletal muscle, visceral, and subcutaneous adipose tissue cross‐sectional areas were calculated based on computed tomography scans, and muscle strength was measured using hand grip tests, 30 seconds chair stand tests, and maximal inspiratory and expiratory pressure tests prior to nCRTx and after nCRTx. Results: A total of 322 patients were included in this study. Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (P = 0.082). Patients with sarcopenia had a significantly lower muscle strength and higher fat percentage. The muscle strength and incidence of sarcopenia increased while the mean body mass index and fat percentage decreased during nCRTx. A body mass index above 25 kg/m 2 was associated with anastomotic leakage (P = 0.032). Other body composition parameters were not associated with post‐operative morbidity. A lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (P = 0.023 and P = 0.009, respectively). In multivariable analysis, a lower number of stands during the 30 seconds chair stand test prior to nCRTx (hazard ratio 0.93, 95% confidence interval 0.87–0.99, P = 0.017) and visceral adipose tissue of >128 cm 2 after nCRTx (hazard ratio 1.81, 95% confidence interval 1.30–2.53, P = 0.001) were associated with worse overall survival. Conclusions: Sarcopenia occurs frequently in patients with oesophageal cancer and is associated with less muscle strength and a higher fat percentage. Body composition changes during nCRTx did not influence survival. Impaired muscle strength and a high amount of visceral adipose tissue are associated with worse survival. Therefore, patients with poor fitness might benefit from preoperative nutritional and muscle strengthening guidance, aiming to increase muscle strength and decrease visceral adipose tissue. However, this should be confirmed in a large prospective study.
Overview
CoChat Summary
TL;DR
In 322 patients with oesophageal cancer treated with neoadjuvant chemoradiation (nCRTx) and surgery, sarcopenia was common (55.6% before and 58.2% after nCRTx) and associated with lower muscle strength and higher fat percentage, but not with post-operative morbidity or survival. Impaired muscle strength and high visceral adipose tissue after nCRTx were associated with worse overall survival.
Key findings
- Sarcopenia was present in 55.6% of patients prior to nCRTx and 58.2% after nCRTx (P = 0.082). Patients with sarcopenia had significantly lower muscle strength and higher fat percentage; for example, after nCRTx, non-dominant handgrip strength was 37.5 ± 9.7 kg vs 44.6 ± 7.8 kg (P = 0.001), 30 s chair stand test was 16.6 ± 5.6 vs 22.1 ± 8.2 stands (P = 0.001), and fat percentage was 30.6 ± 4.5% vs 29.1 ± 5.4% (P = 0.017).
- During nCRTx, the incidence of sarcopenia increased (55.6–58.2%, P = 0.082) while mean BMI and fat percentage decreased (−0.4 kg/m², 95% CI −0.3 to 0.5, P < 0.001; −0.6%, 95% CI −0.04 to 1.2, P = 0.036). All muscle strength tests increased; the strongest increases were maximal expiratory pressure (mean increase 9.4 cmH₂O, 95% CI 3.7–15.1, P = 0.001) and non-dominant handgrip strength (mean increase 1.4 kg, 95% CI 0.5–2.4, P = 0.004).
- A BMI ≥26 kg/m² prior to nCRTx was associated with anastomotic leakage (15.9% of patients with BMI 18–25 kg/m² vs 26.0% with BMI ≥26 kg/m², P = 0.032). Lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (P = 0.023 and P = 0.009, respectively). Other body composition parameters were not associated with post-operative morbidity.
- In multivariable analysis, a lower number of stands during the 30 s chair stand test prior to nCRTx (HR 0.93, 95% CI 0.87–0.99, P = 0.017) and visceral adipose tissue >128 cm² after nCRTx (HR 1.81, 95% CI 1.30–2.53, P = 0.001) were associated with worse overall survival. Sarcopenia itself was not significantly associated with survival (prior to nCRTx median overall survival 48.4 vs 31.8 months, P = 0.148; after nCRTx 37.6 vs 39.2 months, P = 0.805).
Methods
- Retrospective study using a prospectively maintained database of consecutive patients with oesophageal cancer treated with surgery between 1 January 2011 and 1 January 2016 at Amsterdam UMC (location AMC), the Netherlands. Patients were included if they had resectable oesophageal carcinoma treated with nCRTx followed by surgery; exclusion criteria were missing or insufficient-quality diagnostic CT images before and after nCRTx. A total of 322 patients were included; in 175 patients, both CT scans prior to and after nCRTx were available and eligible for analysis.
- Body composition was assessed from CT scans at the midpoint of the third lumbar vertebra (L3): skeletal muscle, visceral, subcutaneous, and total adipose tissue cross-sectional areas and indexes, presence of sarcopenia, body fat percentage, and BMI. Muscle strength was measured prior to and after nCRTx using hand grip tests, 30 s chair stand tests, and maximal inspiratory and expiratory pressure tests.
- Statistical analysis included descriptive statistics, χ² or Fisher’s exact tests, Wilcoxon signed rank test, independent and dependent t-tests, Kaplan–Meier curves with log-rank tests, and Cox proportional hazard models for multivariable analysis with stepwise backwards elimination (P < 0.05 to stay in the model). Missing data were handled with complete case analysis; analyses used SPSS version 25.0, and two-sided P values <0.05 were considered significant.
Limitations
- Stated in the paper: muscle strength was assessed only in patients also included in another study, and this subgroup was much smaller than the total cohort, which may have contributed to selection bias together with the retrospective design. The incidence of sarcopenic obesity was very low, so its influence on post-operative complications or long-term survival could not be assessed properly. Handgrip strength is less reliable in older patients, and the chair stand test can be influenced by co-morbidities; the cohort had a median age of 65 years and almost half had co-morbidities, which may have made muscle strength outcomes less reliable. No standardized cut-off values for sarcopenia exist; the study used Martin et al. cut-offs, which may differ from the Prado et al. population.
- Evident from the text: this was a single-centre retrospective cohort, and missing data were handled with complete case analysis. Paired CT analyses were limited to 175 of 322 patients who had both pre- and post-nCRTx CT scans available and eligible for analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
0 Valid · 0 Not valid · 32 Not checked · 57 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sarcopenia was present in 51.4% of the patients with adenocarcinoma and in 71.7% of the patients with squamous cell carcinoma based on the CT scan prior to nCRTx (P = 0.013).”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Incidence of sarcopenia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A BMI of ≥26 kg/m2 prior to nCRTx was associated with a higher incidence of anastomotic leakage (15.9% of the patients with a BMI between 18 and 25 kg/m2 and 26.0% of the patients with a BMI of ≥26 kg/m2 developed anastomotic leakage, P = 0.032).”
- Also stated in: § Results · plain
“A body mass index above 25 kg/m2 was associated with anastomotic leakage (P = 0.032).”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of body composition and muscle strength on post‐operative complications
plainstates an associationn = 322 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (P = 0.082).”
- Also stated in: § Influence of neoadjuvant chemoradiation on body composition and muscle strength · plain
“the incidence of sarcopenia increased (55.6–58.2%, P = 0.082)”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Abstract > Results
plainn = 322- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Influence of neoadjuvant chemoradiation on body composition and muscle strength · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“a lower number of stands during the 30 seconds chair stand test prior to nCRTx (hazard ratio 0.93, 95% confidence interval 0.87–0.99, P = 0.017)”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Abstract > Results
plainstates an associationn = 322 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Obesity did not significantly influence the incidence of other complications (data not shown).”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of body composition and muscle strength on post‐operative complications
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 89 claims and to verify the 48 references still open.
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
- Probably not a substantial claim. 16
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of neoadjuvant chemoradiation on body composition and muscle strength
“−0.4 kg/m2”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of neoadjuvant chemoradiation on body composition and muscle strength
“95% confidence interval (CI) −0.3 to 0.5”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Influence of body composition and muscle strength on long‐term survival
“visceral adipose tissue of >128 cm2 after nCRTx with impaired survival (hazard ratio 1.41, 95% CI 1.03–1.92, P = 0.34”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Methods > Statistical analysis
“All tests were two‐sided, and P values less than 0.05 were considered significant.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| N0 | 191 (59.5) | 79 (63.7) | 54 (54.0) | 0.131 | 93 (60) | 65 (58.0) | 0.944 | | N1 | 64 (19.9) | 27 (21.8) | 21 (21.0) | 0.131 | 91 (58.7) | 24 (21.4) | 0.944 | | N2–3 | 66 (20.5) | 18 (14.5) | 25 (25.0) | 0.131 | 31 (20.0) | 23 (20.5) | 0.944 |”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Patient characteristics
Reported 155 · recomputed 215
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| R0 resection | 301 (94.1) | 114 (91.2) | 96 (96.0) | 0.151 | 145 (93.5) | 107 (62.2) | 0.405 |”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Patient characteristics
Reported 62.2 · recomputed 95.535714
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total adipose tissue indexa (cm2/m2) | 106.2 ± 48.3 | 203.4 ± 54.7 | 0.692 | 97.9 ± 43.7 | 97.4 ± 53.1 | 0.924 |”
§ Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment > Results > Relation between sarcopenia, body composition, and muscle strength
Reported 203.4 · recomputed 103.4
3 more findings
Create a free account to see every finding of this check.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · BMJ · doi:10.1136/bmj.39335.541782.ad · Cited by 10,766
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Self-citationInflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 1×
“Sarcopenia reduces physical activity, which leads to decreased energy and an increased risk of obesity.(15) When sarcopenia is accompanied by a high fat mass, it is called sarcopenic obesity.”
BackgroundPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 1×
“This suggests that not only the amount of muscle but also the quality of the muscle is of influence, and younger patients might have better muscle quality.(44,45)”
BackgroundA 30-s chair-stand test as a measure of lower body strength in community-residing older adults.
Jones, C. J., Rikli, R. E., & Beam, W. C. (1999) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1999.10608028 · Cited by 2,921
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Research works printed but not linked: 1
- Boer Maureen M, 2011, Herziene richtlijn ‘Oesofaguscarcinoom’, Ned Tijdschr Geneeskd, 155, A3732
Cited by
Jogiat, U., Sasewich, H., Turner, S. R., Baracos, V. E., Eurich, D. T., Filafilo, H., & Bédard, E. L. R. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005452 · Cited by 87
Jogiat, U., Bédard, E. L. R., Sasewich, H., Turner, S. R., Eurich, D. T., Filafilo, H., & Baracos, V. E. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13082 · Cited by 71
Song, M., Zhang, Q., Tang, M., Zhang, X., Ruan, G., Zhang, X., Zhang, K., Ge, Y., Yang, M., Li, Q., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12778 · Cited by 71
Adiposity and cancer survival: a systematic review and meta-analysis
Cheng, E., Kirley, J., Feliciano, E. M. C., & Caan, B. J. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01613-7 · Cited by 66
Halliday, L. J., Boshier, P. R., Doganay, E., Wynter-Blyth, V., Buckley, J., & Moorthy, K. (2022) · Diseases of the Esophagus · doi:10.1093/dote/doac046 · Cited by 63
Self-citationWang, P., Wang, S., Li, X., Lin, G., Ma, Y., Xiao, R., Li, H., Qiu, M., & Yang, F. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.106206 · Cited by 50
Matsui, R., Watanabe, J., Banno, M., Inaki, N., & Fukunaga, T. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac273 · Cited by 33
Zhang, F., Chen, X.-L., Wu, Q., Dong, W.-X., Dong, Q., Shen, X., Shi, H., Yu, Z., & Zhuang, C. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa305 · Cited by 33
Chen, F., Chi, J., Zhao, B. Q., Mei, F., Gao, Q., Zhao, L., & Ma, B. (2022) · Diseases of the Esophagus · doi:10.1093/dote/doab100 · Cited by 32
Qian, J., Si, Y., Zhou, K., Tian, Y., Guo, Q., Zhao, K., & Yu, J. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02296-9 · Cited by 32
Xu, X., Jiang, X., Xu, Q., Xu, H., Luo, J., Cui, Y., Ding, L., & Zhu, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.892935 · Cited by 30
Surgical Therapy of Esophageal Adenocarcinoma—Current Standards and Future Perspectives
Schröder, W., Gisbertz, S. S., Voeten, D. M., Gutschow, C. A., Fuchs, H. F., & Henegouwen, M. I. V. B. (2021) · Cancers · doi:10.3390/cancers13225834 · Cited by 28
Self-citationChen, Y., Jia, H., Ye, R., Zhou, Z., Chen, W., Zheng, M., & Yuanyuan, Z. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13785 · Cited by 25
Luo, L., Fan, Y., Wang, Y., Wang, Z., & Zhou, J. (2024) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2024.100436 · Cited by 25
Tweed, T. T. T., van der Veen, A., Tummers, S., van Dijk, D. P. J., Luyer, M. D. P., Ruurda, J. P. H., van Hillegersberg, R., Stoot, J. H. M. B., Tegels, J. J. W., Hulsewé, K. W. E., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-022-05321-0 · Cited by 24
Self-citationZhang, Y., Li, Z., Jiang, L., Xue, Z., Ma, Z., Kang, W., Ye, X., Liu, Y., Jin, Z., & Yu, J. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12861 · Cited by 23
Early mobilization after esophageal cancer surgery: a retrospective cohort study
Schuring, N., Geelen, S. J. G., Henegouwen, M. I. V. B., Steenhuizen, S. C. M., van der Schaaf, M., van der Leeden, M., & Gisbertz, S. S. (2022) · Diseases of the Esophagus · doi:10.1093/dote/doac085 · Cited by 22
Self-citationCereda, E., Tancredi, R. J., Klersy, C., Lobascio, F., Crotti, S., Masi, S., Cappello, S., Stobäus, N., Tank, M., Cutti, S., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4362 · Cited by 17
Zheng, K., Liu, X., Li, Y., Cui, J., & Li, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-63806-1 · Cited by 12
Gooszen, J. A. H., Eshuis, W. J., Blom, R. L. G. M., van Dieren, S., Gisbertz, S. S., & Henegouwen, M. I. V. B. (2022) · Surgery · doi:10.1016/j.surg.2022.01.003 · Cited by 12
Self-citationKurita, D., Sakurai, T., Utsunomiya, D., Kubo, K., Fujii, Y., Kanematsu, K., Ishiyama, K., Oguma, J., & Daiko, H. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12002-4 · Cited by 10
Fat quantification: Imaging methods and clinical applications in cancer
Yan, S. Y., Yang, Y., Jiang, X. Y., Hu, S., Su, Y. Y., Yao, H., & Hu, C. H. (2023) · European Journal of Radiology · doi:10.1016/j.ejrad.2023.110851 · Cited by 10
Zhou, D., Zuo, J., Zeng, C., Zhang, L., Gao, X., Li, G., & Wang, X. (2024) · Nutrition · doi:10.1016/j.nut.2024.112472 · Cited by 9
Cameron, M. E., Ayzengart, A., Oduntan, O., Judge, S. M., Judge, A. R., & Awad, Z. T. (2023) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000535 · Cited by 9
Yan, X., Zhu, J., Wang, J., Lu, Y., Ye, X.-Z., Sun, X., Jiang, H., Li, Z., He, C., Zhai, W., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1425317 · Cited by 9
Li, L., XinSheng, Z., Xiang, H., Liu, Z., Liu, L., XiuMing, L., Li, Y., Chen, J., KeMing, Z., HongChi, W., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1424039 · Cited by 7
Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer
Freckelton, J., Rajagopalan, A., Moore, G. T., & Croagh, D. G. (2024) · Pancreas · doi:10.1097/mpa.0000000000002319 · Cited by 7
Physical fitness predicts post-esophagectomy complications after chemoradiotherapy: a pilot study
Chiu, C., Chang, W., Yang, L., Chao, Y., Chen, W., Liu, Y., Tsao, Y.-T., Chang, Y., & Huang, S.-C. (2025) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-025-01158-7 · Cited by 6
do Nascimento, R. A., Vieira, M. C. A., Gonçalves, R. S. D. S. A., Moreira, M. A., de Morais, M. S. M., da Câmara, S. M. A., & Maciel, Á. C. C. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04532-x · Cited by 5
Curtis, A. R., Prado, C. M. M., Orellana, L., Daly, R. M., Bauer, J. D., Denehy, L., Edbrooke, L., Baguley, B. J., Alston, L. V., Hardcastle, N., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.11.016 · Cited by 5
den Boer, R. B., Defize, I. L., Veldhuis, W. B., Steenhagen, E., Kerst, A., van Hillegersberg, R., de Jong, P. A., & Ruurda, J. P. H. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.107017 · Cited by 5
Fu, B., Wei, L., Wang, C., Xiong, B., Bo, J., Jiang, X., Zhang, Y., Jia, H., & Dong, J. (2024) · Journal of X-Ray Science and Technology · doi:10.3233/xst-230212 · Cited by 4
Evolving concepts on perioperative nutrition of sarcopenic cancer patients
Bozzetti, F. (2022) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2022.10.008 · Cited by 3
Qin, Y., Chen, J., Li, Y., Qin, R., & Li, S. (2025) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2025.100830 · Cited by 3
Influence of body composition measures on chyle leak after oesophagectomy
Halle-Smith, J. M., Siddaiah‐Subramanya, M., Ghoneim, A. H., Almonib, A., & Tan, B. H. L. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1580 · Cited by 3
Ding, F., Nakamoto, A., Zheng, X., Honda, T., Wang, G., Liu, Y., Fukui, H., Ota, T., Yanagawa, M., & Tomiyama, N. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70366 · Cited by 2
Elias, G. M., Barreto, A. B., Martucci, R. B., & Souza, N. C. (2026) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n1.5465es · Cited by 1
Impact of Cancer-Related Sarcopenia on Systemic Immune Status
Liu, S., & Mogi, M. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2022_108 · Cited by 1
葛益众, Liu, C., Zhang, Q., Liu, T., Deng, L., Song, M., Ruan, G., Song, C.-H., Yao, Q.-H., Shen, X., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10638-6 · Cited by 1
Özveren, A., Çil, T., Bıçaklı, D. H., Gultekin, G., Doğan, D., Zengin, C., Bilici, A. E., Sabır, S., Erçelep, Ö., Ekşi, F., et al. (2025) · Nutrition · doi:10.1016/j.nut.2025.113029 · Cited by 1
Tseng, W. H.-S., Huang, S.-C., Wang, S. C., Lin, J., Zhang, P., Liu, Y.-C., Chao, Y., & Chiu, C. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i8.108600 · Cited by 1
Boshier, P. R., Gisbertz, S. S., Hanna, G. B., Klevebro, F., Okamura, A., Pramesh, C. S., Reynolds, J. V., Rosati, R., Skipworth, R. J. E., Tsunoda, S., et al. (2026) · Diseases of the Esophagus · doi:10.1093/dote/doaf128 · Cited by 1
Self-citationQian, D., Shen, P., Zhu, J., Ji, S., & Kong, Y. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03338-0 · Cited by 1
Liu, Q., Hu, J., Liu, L., He, W., Hou, J., Shu, Y., & Wang, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14703-x · Cited by 1
Chiang, H., Yang, C.-J., Wang, J.-Y., Lin, F., Chiang, N., Chung, T.-J., Tseng, Y., Sheu, B., & Chang, W. (2025) · Nutrition and Cancer · doi:10.1080/01635581.2025.2519971 · Cited by 1
Muscle Health and Prognosis in Patients With Cancer: New Insights
Cereda, E., Casirati, A., González, M. C., Souza, N. C., Prado, C. M. M., Ford, K. L., Maurício, S. F., Correia, M. I. T. D., Pedrazzoli, P., & Caccialanza, R. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70292 · Cited by 1
van Egmond, & Maarten, A. D. H. (2020) · UvA-DARE (University of Amsterdam) · Cited by 1
Huang, G., Zhu, J., He, B., Zhang, W., Huang, W., Tang, X., Zhang, L., & Wang, Q. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-19816-6 · Cited by 1
Юрьевич, Д. С., Kapshuk, Y. Y., & Akopov, A. L. (2023) · Grekov s Bulletin of Surgery · doi:10.24884/0042-4625-2023-182-2-78-85 · Cited by 1
Ming, J., Du, R., Geng, J., Li, S., Liu, Z., Cai, Y., Zhu, X., Zhang, Y., Wang, H., Wang, Z., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.988632 · Cited by 1
Can Goals for Early Postoperative Ambulation After Esophagectomy Be Established?
Schuring, N., & Gisbertz, S. S. (2024) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-031-78663-1_40 · Cited by 1
Self-citationPhysical Function and Nutrition in Patients with Esophageal Cancer and Head and Neck Cancer
Suzuki, M., & Hashida, N. (2022) · Springer eBooks · doi:10.1007/978-981-19-6710-8_21
Elhadjène, N., Grange, R., Williet, N., Roy, B. L., Kaczmarek, D., Freyssenet, D. G., & MOREL, J. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103406
Elias, G. M., Barreto, A. B., Martucci, R. B., & Souza, N. C. (2026) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n1.5465en
Nascimento, M. D. M., Ihle, A., Ferrari, G., Gouveia, É. R., Peralta, M., & Marques, A. (2026) · Journal of Applied Gerontology · doi:10.1177/07334648261435802
Nascimento, M. D. M., Ihle, A., Ferrari, G., Gouveia, É. R., Peralta, M., & Marques, A. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106295
Sato, S., Nakatani, E., Hawke, P., Tsuru, M., Nagai, E., Taki, Y., Nishida, M., Watanabe, M., Ohata, K., & Kanemoto, H. (2026) · Esophagus · doi:10.1007/s10388-026-01196-1
Bulgakova, S. V., Kurmaev, D. P., Treneva, E. V., Pervyshin, N. A., & Киселева, К. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-222-2-15-21
Qian, D., Shen, P., Zhu, J., Ji, S., & Kong, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26684169
Multimodal prehabilitation: program considerations for patients with esophageal cancer
St-Pierre, J. (2025) · eScholarship@McGill (McGill) · doi:10.82308/51477
Li, L., Zhang, J., Wang, H., Gou, C., Wang, X., He, Y., & Tian, Y. (2026) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-2026-0722
Xu, X.-Y., Jiang, X.-M., Xu, Q., Xu, H., Luo, J.-H., Yao, C., Ding, L.-Y., & Zhu, S.-Q. (2022) · doi:10.3389/fonc.2022.892935.s001
Qi, W., Zhao, C., Wang, M. X., Li, S., Yu, B., Yang, X., Yao, L., Chen, J., & Zhao, S. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103129
Yan, X., Zhu, J., Wang, J., Lu, Y., Ye, X., Sun, X., Jiang, H., Li, Z., He, C., Zhai, W., et al. (2024) · doi:10.3389/fnut.2024.1425317.s001
Metadata
- Authors
- Hagens, E. R. C., Feenstra, M. L., van Egmond, M. A., van Laarhoven, H. W. M., Hulshof, M. C. C. M., Boshier, P. R., Low, D. E., van Berge Henegouwen, M. I., & Gisbertz, S. S.
- Affiliations
- Amsterdam University Medical Centers (NL)
- Virginia Mason Medical Center (US)
- Department of Surgery Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands
- Corresponding author
- Gisbertz, Suzanne S.
- ORCID
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2020-02-25
- Volume
- 11
- Issue
- 3
- Pages
- 756-767
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- PMC
- PMC7296271
- OpenAlex
- W3007363454
- Cited by
- 65
- References
- 55
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 13 · 2023: 6 · 2022: 17 · 2021: 5 · 2020: 2
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Cachexia Sarcopenia and Muscle (publishedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Cancer Research UK (27981)
- National Institute for Health and Care Research (ACF-2014-21-007, CL-2017-21-005)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- esophageal cancer, sarcopenia, body composition, muscle strength, neoadjuvant chemoradiotherapy, visceral adipose tissue, subcutaneous adipose tissue, grip strength, chair stand test, anastomotic leakage, postoperative morbidity, overall survival, body mass index, esophagectomy, skeletal muscle area, maximal inspiratory pressure
- MeSH terms
- Body Composition, Esophageal Neoplasms, Female, Humans, Middle Aged, Retrospective Studies, Treatment Outcome, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.